Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Filed with HKEX · Stock code 2171 · · 10 pages · English
Summary by 6ix AI
It reports on the movements in authorized and registered share capital, as well as changes in issued shares and treasury shares. The document confirms compliance with public float requirements and provides details on share options and other agreements related to share issuance.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
CARsgen Therapeutics Holdings Ltd. on 6ix
Earlier from CARsgen Therapeutics
- List of directors and their roles and functions
- Resignation of non-executive director and non-compliance with rule 3.21 of the listing rules
- Voluntary announcement - first patient dose of CT1190B in china phase i registrational trial
- Interim report 2026
- CARsgen Therapeutics Announces 2026 Interim Results
Later from CARsgen Therapeutics
All CARsgen Therapeutics news releasesFollow CARsgen Therapeutics into a list and get an email when it puts out news.
Follow CARsgen Therapeutics